Skip to main content
. 2015 Dec 24;7:74. doi: 10.1186/s13195-015-0161-y

Fig. 4.

Fig. 4

Neurogranin distinguishes Alzheimer’s disease (AD) from non-AD subjects well. Receiver operating characteristic curves of neurogranin (black circles), YKL-40 (black triangles), and the product of neurogranin × YKL-40 (white circles) for the discrimination between samples within the non-AD group and the AD group. AUC area under the curve